We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Targeting NP cell senescence in IVDD

    Rebecca Kelsey in Nature Reviews Rheumatology
    Article 26 February 2024
  2. The effect of nurse practitioner (NP-led) care on health-related quality of life in people with multiple sclerosis – a randomized trial

    Background

    Care for People with Multiple Sclerosis (PwMS) is increasingly complex, requiring innovations in care. Canada has high rates of MS; it is...

    Penelope Smyth, Kaitlyn E. Watson, ... Ross T. Tsuyuki in BMC Neurology
    Article Open access 25 July 2022
  3. COMMunity of Practice And Safety Support for Navigating Pain (COMPASS-NP): study protocol for a randomized controlled trial with home care workers

    Background

    Chronic pain is a prevalent and costly problem that often has occupational origins. Home care workers (HCWs) are at high risk for...

    Ryan Olson, Jennifer A. Hess, ... Sean P.M. Rice in Trials
    Article Open access 10 April 2023
  4. Pharmacokinetics and Biochemical Efficacy of an α1-Proteinase Inhibitor (Aralast NP) in α1-Antitrypsin Deficiency: a Cross-Product Retrospective Comparability Analysis

    Introduction

    Augmentation therapy with plasma-derived α 1 -proteinase inhibitor (A1PI) products is currently the only approved disease-specific therapy...

    Zhaoyang Li, Ryan M. Franke, ... Leman Yel in Pulmonary Therapy
    Article Open access 24 August 2022
  5. Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial

    Background

    The pivotal ASPECT-NP trial showed ceftolozane/tazobactam was non-inferior to meropenem for the treatment of ventilated...

    Ignacio Martin-Loeches, Andrew F. Shorr, ... Christopher J. Bruno in Annals of Intensive Care
    Article Open access 11 February 2023
  6. Outcomes in participants with failure of initial antibacterial therapy for hospital-acquired/ventilator-associated bacterial pneumonia prior to enrollment in the randomized, controlled phase 3 ASPECT-NP trial of ceftolozane/tazobactam versus meropenem

    Background

    Ceftolozane/tazobactam, a combination antibacterial agent comprising an anti-pseudomonal cephalosporin and β-lactamase inhibitor, is...

    Marin H. Kollef, Jean-François Timsit, ... Christopher J. Bruno in Critical Care
    Article Open access 01 December 2022
  7. Rydberg energies and transition probabilities of Li I for npms (m ≤ 5) transitions

    Background

    Mathematical modeling provides grounds for understanding scientific systems theoretically. It serves as a guide for experimentalists in...

    R. Siddiq, M. N. Hameed, ... Z. Uddin in Beni-Suef University Journal of Basic and Applied Sciences
    Article Open access 26 March 2022
  8. Measuring the effects of nurse practitioner (NP)-led care on depression and anxiety levels in people with multiple sclerosis: a study protocol for a randomized controlled trial

    Background

    Canada has one of the highest rates of multiple sclerosis (MS) in the world. Treatments and supports for people with MS (PwMS) have become...

    Penelope Smyth, Kaitlyn E. Watson, Ross T. Tsuyuki in Trials
    Article Open access 08 November 2021
  9. Ceftolozane/tazobactam probability of target attainment and outcomes in participants with augmented renal clearance from the randomized phase 3 ASPECT-NP trial

    Background

    The randomized, double-blind, phase 3 ASPECT-NP trial evaluated the efficacy of 3 g of ceftolozane/tazobactam (C/T) versus 1 g of meropenem...

    Andrew F. Shorr, Christopher J. Bruno, ... Marin H. Kollef in Critical Care
    Article Open access 02 October 2021
  10. Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial

    Background

    Ceftolozane/tazobactam is approved for treatment of hospital-acquired/ventilator-associated bacterial pneumonia (HABP/VABP) at double the...

    Jean-François Timsit, Jennifer A. Huntington, ... Christopher J. Bruno in Critical Care
    Article Open access 11 August 2021
  11. The ceramide [NP]/[NS] ratio in the stratum corneum is a potential marker for skin properties and epidermal differentiation

    Background

    Specific species of ceramides (Cer), major constituents of lipids in the stratum corneum (SC), are decreased and are correlated with SC...

    Urara Yokose, Junko Ishikawa, ... Atsushi Hatamochi in BMC Dermatology
    Article Open access 31 August 2020
  12. Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP Trial

    Introduction

    Hospital-acquired and ventilator-associated bacterial pneumonia (HABP and VABP) are associated with significant healthcare resource...

    Thomas Lodise, Joe Yang, ... Marin Kollef in Infectious Diseases and Therapy
    Article Open access 30 September 2020
  13. Cross cultural adaptation and validation of burn specific health scale- brief in Nepali (BSHS-B-Np)

    Background

    Burns are a global health problem affecting the survivors and disrupting many aspects of their lives. It is the second most common injury...

    Regan Shakya, Misu Manandhar, ... Archana Shrestha in Journal of Patient-Reported Outcomes
    Article Open access 22 April 2020
  14. Orthopedics for Physician Assistant and Nurse Practitioner Students An Introductory Guide

    This practical introductory guide provides PA/NP students with the tools to recognize and begin treatment of the most common orthopedic problems, to...
    John A. Gracy
    Textbook 2022
  15. Real-Life Response to Biologics in Severe Asthma with Nasal Polyposis: Insights from the Belgian Severe Asthma Registry

    Background

    Nasal polyposis (NP) is a comorbidity of type 2 severe asthma (SA) which could influence response to SA biologics.

    Methods

    We evaluated...

    Femke Demolder, Eef Vanderhelst, ... Shane Hanon in Lung
    Article 15 July 2024
  16. Magnetic Resonance Imaging-Negative Cerebral Amyloid Angiopathy: Cerebrospinal Fluid Amyloid-β42 over Amyloid Positron Emission Tomography

    Background

    Cerebral amyloid angiopathy (CAA) pathology is becoming increasingly important in Alzheimer’s disease (AD) because of its potential link to...

    J.-M. Pyun, M. J. Kang, ... SangYun Kim in The Journal of Prevention of Alzheimer's Disease
    Article 05 March 2024
  17. The optimal ratio of endoscope-sheath diameter with negative-pressure ureteral access sheath: an in vitro research

    Purpose

    To maintain safe intrarenal pelvic pressure (IPP), the combination of flexible ureteroscope (fURS) and traditional ureteral access sheath...

    **gyu Shi, Ting Huang, ... Li Fang in World Journal of Urology
    Article 07 March 2024
  18. Submucosal Trans-Septal Suturing Technique After a Septal Extension Graft with Porous High-Density Polyethylene: A Technical Report

    Background

    Porous high-density polyethylene (pHDPE) is an alternative material for a septal extension graft (SEG) in oriental rhinoplasty when...

    **n Huang, Yufeng Gan, ... **de Lin in Aesthetic Plastic Surgery
    Article 03 June 2024
  19. Short- and long-term post-nephrectomy outcomes for retroperitoneal liposarcoma from a high-volume sarcoma center: a propensity score matching analysis

    Background

    Multivisceral en bloc resection with the ipsilateral kidney is commonly performed in patients with retroperitoneal liposarcoma (RLPS). We...

    Guoqiang Xue, Zhen Wang, ... Chunyi Hao in International Journal of Clinical Oncology
    Article 23 April 2024
Did you find what you were looking for? Share feedback.